Arrowhead Research reported 0 in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 84.36M 6.68M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Arrowhead Research ARWR:US 0 0
Bluebird Bio BLUE:US $ 13.5M 4.58M
Heron Therapeutics HRTX:US $ 42.8M 0.17M
IONIS PHARMACEUT IONS:US $ 24.1M 1.9M
Ligand Pharmaceuticals LGND:US $ 39.95M 3.01M
Nektar Therapeutics NKTR:US $ 14.62M 2.19M
Novartis NOVN:VX SF 7111M 114M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 15.08M 2.62M
Vertex Pharmaceuticals VRTX:US $ 321.62M 22.76M
YTE INCY:US $ 16.68M 0.02M